You are here

Failure of two distinct anti-apoptotic approaches to reduce mortality in experimental cerebral malaria.

TitleFailure of two distinct anti-apoptotic approaches to reduce mortality in experimental cerebral malaria.
Publication TypeJournal Article
Year of Publication2008
AuthorsHelmers, AJ, Lovegrove, FE, Harlan, JM, Kain, KC, W Liles, C
JournalAm J Trop Med Hyg
Volume79
Issue6
Pagination823-5
Date Published2008 Dec
ISSN1476-1645
KeywordsAnimals, Antimalarials, Apoptosis, ATP-Binding Cassette Transporters, Female, Gene Expression Regulation, Humans, Malaria, Cerebral, Male, Mice, Mice, Inbred C57BL, Mice, Transgenic, Oligopeptides, Plasmodium berghei, Proto-Oncogene Proteins c-bcl-2, Time Factors
Abstract

Cerebral malaria is responsible for a high proportion of mortality in human Plasmodium falciparum infection. Previous studies have reported the presence of apoptosis in endothelial cells, astrocytes, neurons, and glial cells in experimental murine cerebral malaria caused by infection with Plasmodium berghei ANKA. Using this model, we tested two strategies, which have been shown to improve survival in murine models of sepsis: 1) treatment with z-VAD, a pancaspase inhibitor; and 2) overexpression of Bcl-2 using transgenic mice expressing human Bcl-2 (which prevents the release of apoptotic mediators from the mitochondria) from a myeloid cell promoter. Neither of these anti-apoptotic strategies, previously shown to provide therapeutic benefit in sepsis, improved survival in experimental cerebral malaria.

Alternate JournalAm. J. Trop. Med. Hyg.
PubMed ID19052286